Anthony Bergmann

2017

In 2017, Anthony Bergmann earned a total compensation of $220.1K as Chief Financial Officer at Capricor Therapeutics.

Compensation breakdown

Option Awards$64,610
Salary$154,500
Other$1,000
Total$220,110

Bergmann received $154.5K in salary, accounting for 70% of the total pay in 2017.

Bergmann also received $64.6K in option awards and $1K in other compensation.

Rankings

In 2017, Anthony Bergmann's compensation ranked 13,908th out of 14,666 executives tracked by ExecPay. In other words, Bergmann earned more than 5.2% of executives.

ClassificationRankingPercentile
All
13,908
out of 14,666
5th
Division
Manufacturing
5,455
out of 5,768
5th
Major group
Chemicals And Allied Products
1,958
out of 2,074
6th
Industry group
Drugs
1,632
out of 1,730
6th
Industry
Pharmaceutical Preparations
1,248
out of 1,329
6th
Source: SEC filing on April 29, 2019.

Bergmann's colleagues

We found three more compensation records of executives who worked with Anthony Bergmann at Capricor Therapeutics in 2017.

2017

Linda Marbán

Capricor Therapeutics

Chief Executive Officer

2017

Deborah Ascheim

Capricor Therapeutics

Chief Medical Officer

2017

Karen Krasney

Capricor Therapeutics

General Counsel

News

You may also like